Dcf Advisers, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Dcf Advisers, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.5 - $1.06 $77,250 - $163,770	-154,500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$0.67 - $1.51 $155,087 - $349,525	-231,474 Reduced 59.97%	154,500 $201,000
Q2 2021 Aug 13, 2021	SELL	$0.75 - $1.1 $10,519 - $15,428	-14,026 Reduced 3.51%	385,974 $299,000
Q1 2021 May 12, 2021	BUY	$0.96 - $1.74 $90,912 - $164,779	94,701 Added 31.02%	400,000 $420,000
Q4 2020 Feb 12, 2021	SELL	$0.76 - $1.47 $187,336 - $362,349	-246,496 Reduced 44.67%	305,299 $415,000
Q3 2020 Nov 13, 2020	SELL	$0.67 - $0.96 $8,040 - $11,520	-12,000 Reduced 2.13%	551,795 $423,000
Q2 2020 Aug 13, 2020	SELL	$0.52 - $0.92 $29,226 - $51,708	-56,205 Reduced 9.07%	563,795 $436,000
Q1 2020 May 12, 2020	BUY	$0.6 - $2.31 $207,594 - $799,239	345,991 Added 126.27%	620,000 $372,000
Q4 2019 Feb 12, 2020	BUY	$0.63 - $2.27 $172,625 - $622,000	274,009 New	274,009 $622,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcf Advisers, LLC with notifications on news.